Goebel H H
Neuropediatrics. 1984 Sep;15 Suppl:97-106. doi: 10.1055/s-2008-1052389.
GM1 and GM2 gangliosidoses are progressive neurodegenerative diseases which accumulate intralysosomal gangliosides--and to a lesser extent oligosaccharides--chiefly in the central and peripheral nervous system owing to deficiencies of beta-galactosidase and hexosaminidases A or/and B, respectively. This intralysosomal "storage" in neuronal pericarya and their processes, and subsequent loss of such nerve cells provide the background for clinical symptoms of the central nervous system and the retina, while involvement of the peripheral nervous system and the visceral organs largely remains free of clinical findings. The morphological involvement of the latter organs is widespread though varying, thus allowing morphological investigations of lymphocytes, skin, or rectum for morphological diagnosis and as a screening procedure.
GM1和GM2神经节苷脂贮积症是进行性神经退行性疾病,由于分别缺乏β-半乳糖苷酶和己糖胺酶A或/和B,溶酶体内神经节苷脂(以及程度较轻的寡糖)主要在中枢和周围神经系统中蓄积。这种在神经元胞体及其突起中的溶酶体内“贮积”,以及随后这些神经细胞的丧失,构成了中枢神经系统和视网膜临床症状的基础,而周围神经系统和内脏器官的受累在很大程度上没有临床症状。后一类器官的形态学受累广泛但有所不同,因此可对淋巴细胞、皮肤或直肠进行形态学检查以进行形态学诊断和作为筛查程序。